3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
34
Lymphoma, Non-Hodgkin
31
Lymphoma
20
Lymphoma, Mantle-Cell
18
Multiple Myeloma
17
Lymphoma, Follicular
16
Lymphoma, Large B-Cell, Diffuse
14
Hodgkin Disease
11
Lymphoma, B-Cell, Marginal Zone
9
Recurrence
6
Leukemia
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Waldenstrom Macroglobulinemia
4
Neoplasms, Plasma Cell
4
Lymphoma, B-Cell
3
Leukemia, Lymphoid
3
Hematologic Diseases
3
Burkitt Lymphoma
3
Small Cell Lung Carcinoma
2
Sezary Syndrome
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Extranodal NK-T-Cell
2
Leukemia, Hairy Cell
2
Interventions
fludarabine phosphate
2
Whole-Body Irradiation
2
Mycophenolic Acid
2
obinutuzumab
1
letermovir
1
carmustine, poliferprosan 20 drug combination
1
Tacrolimus
1
Stem Cell Transplantation
1
Peripheral Blood Stem Cell Transplantation
1
Melphalan
1
Hematopoietic Stem Cell Transplantation
1
Etoposide
1
Cytarabine
1
Cyclosporins
1
Cyclosporine
1
Cyclophosphamide
1
Carmustine
1
6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)imidazo(1,2-a)pyrazin-8-amine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Prolymphocytic, B-Cell
×
Bendamustine Hydrochloride
×
Clear all
No trials found.